Form 4: LifeStance Health Director Acquires Shares
Statement of Changes in Beneficial Ownership
LifeStance Health Group, Inc. Director Robert Bessler acquired 17,746 restricted stock units.
Summary
- Director Robert Bessler acquired 17,746 restricted stock units (RSUs) on July 2, 2026.
- Each RSU represents a contingent right to receive one share of LifeStance Health Group, Inc. common stock.
- Following this acquisition, Bessler beneficially owns 75,365 shares of common stock directly.
- Additionally, Bessler has indirect beneficial ownership of 539,763 shares held by Vitthal LLC, 656,560 shares held by Shama LLC, and 36,363 shares held by Alpine Glow Capital, where he is the manager and sole member of Alpine Glow Capital.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive filing. The acquisition of stock by a director is generally seen as a positive signal of confidence, but it is a standard disclosure related to compensation rather than a new strategic investment or a significant personal purchase.
Positives
- Director acquisition of company stock can signal confidence in the company's future prospects.
- The acquisition of RSUs indicates a form of compensation or incentive for the director.
Future Outlook
No specific future outlook or guidance is provided in this filing, as it pertains to a change in beneficial ownership.
Industry Context
StockSavvy.ai notes that Form 4 filings, like this one from LifeStance Health (LFST), are standard disclosures for insider transactions. Such filings are closely watched by investors to gauge management's confidence in the company's performance and future prospects. The acquisition of RSUs by a director is a common form of executive compensation and can be interpreted as a positive signal.
Stakeholder Impact
- Shareholders: May view the director's acquisition of RSUs as a positive signal of confidence in the company's future performance.
- Employees: The RSU grant is a form of compensation, impacting the director's remuneration.
- Management: The filing is a routine disclosure requirement for management and directors.
Key Dates
| Date | Description |
|---|---|
| 07/02/2026 | Transaction Date for acquisition of restricted stock units. |
| 07/07/2026 | Date of signature for the filing. |
Keywords
LifeStance Health, LFST, Form 4, Insider Trading, Director, Stock Acquisition, RSU, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.